![Mark Stenhouse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Stenhouse
Direktor/Vorstandsmitglied bei
PHATHOM PHARMACEUTICALS, INC.
Vermögen: 287 700 $ am 31.05.2026
Profil
Mark Stenhouse is currently an Independent Director at Phathom Pharmaceuticals, Inc. since 2020.
Formerly, Mr. Stenhouse was Chief Operating Officer at Prometheus Biosciences, Inc. from 2021 to 2023, General Manager-Screening at EXACT Sciences Corp.
from 2019 to 2021, Director at Prometheus Laboratories, Inc. from 2018 to 2020, Vice President-U.S.
Immunology at AbbVie, Inc. from 2016 to 2018, and Vice President-US Immunology at Abbott Laboratories from 2006 to 2010.
Mr. Stenhouse completed undergraduate education at the College of Charleston.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.05.2026 | 30’000 ( 0.04% ) | 287 700 $ | 31.05.2026 |
Aktive Positionen von Mark Stenhouse
| Unternehmen | Position | Beginn |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 17.03.2020 |
Ehemalige bekannte Positionen von Mark Stenhouse
| Unternehmen | Position | Ende |
|---|---|---|
| PROMETHEUS BIOSCIENCES, INC. | Geschäftsführer | 16.06.2023 |
| EXACT SCIENCES CORPORATION | Corporate Officer/Principal | 01.01.2021 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Direktor/Vorstandsmitglied | 01.10.2020 |
| ABBVIE INC. | Corporate Officer/Principal | 01.03.2018 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.03.2010 |
Ausbildung von Mark Stenhouse
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
EXACT Sciences Corp.
 EXACT Sciences Corp. Medical SpecialtiesHealth Technology Develops proprietary technologies for the detection of cancer | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
College of Charleston
 College of Charleston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for immune-mediated diseases | Health Technology |
Phathom Pharmaceuticals, Inc.
 Phathom Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel treatments for gastrointestinal diseases and disorders | Health Technology |
